Mounjaro manufacturer to hike UK price of weight loss drug by up to 170%
The new price, announced by manufacturer Eli Lilly on Thursday, also applies to Lilly's type 2 diabetes medicine that has the same name.
The price for a month's supply of the highest dose of the medicine will increase from £122 to £330, Lilly said, adding the adjustment will be made next month.
The higher price will not affect those prescribed the medicine through the NHS, which has a separate deal, a Lilly spokesperson said.
The US drugmaker said that when it launched Mounjaro in the UK it agreed to a list price "significantly below" that in its three other European markets to prevent delays in availability through the NHS.
"We are now aligning the list price more consistently," Lilly said.
Lilly did not say what price it has agreed with the NHS, but said it was working with private UK healthcare providers who can set their own prices, such as online pharmacies, to ensure the medicines remain available.
It follows Sky News earlier this month revealing only eight of 42 NHS Integrated Care Boards in England were providing the weight loss treatment to patients, and many of the rest were unable to guarantee when it would be available.
2:32
Lilly's decision comes as US President Donald Trump is pushing for lower domestic prices while encouraging price hikes overseas.
The US pays more for prescription drugs than any other country, often nearly three times as much as other developed
nations.
Mr Trump says he wants to narrow this gap to stop Americans from being "ripped off".
The company issued a statement online saying: "Lilly supports the administration's goal of keeping the United States the world's leading destination for biopharmaceutical research and manufacturing, and the objective of more fairly sharing the costs of breakthrough medical research across developed countries.
"This rebalancing may be difficult, but it means the prices for medicines paid by governments and health systems need to increase in other developed markets like Europe in order to make them lower in the US."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
30 minutes ago
- The Independent
What is sloth fever? Symptoms and advice after UK Oropouche virus cases
The UK's health security watchdog has issued an urgent warning as cases of a deadly malaria-like ' sloth virus ' were found in Britain for the first time. Three cases of Oropouche virus, which naturally occurs in sloths, primates and birds, were reported across Britain between January and June 2025, according to the UK Health Security Agency (UKHSA. All three cases were in people who had returned to the UK after travelling abroad to Brazil after a surge of virus infections across the region. In some cases, the tropical disease can lead to meningitis and death, with two people in Brazil dying from the virus over the last few years. Here, The Independent takes a look at Oropouche virus symptoms and what experts say to do if you think you have the disease. Signs and symptoms of Oropouche virus disease fever headache joint pain muscle aches chills nausea and vomiting rash sensitivity to light dizziness pain behind the eyes How is it spread and how to avoid it? The lesser-known infection is spread through bites from small midges and some mosquitos, and can also be transmitted through sexual activity. It is also feared the disease can be spread from mothers to babies during pregnancy, which can cause congenital or developmental abnormalities, according to the UKHSA. There is no cure, but there are preventative measures travellers can take like wearing long-sleeved clothing and using insect repellent to ward off midges. These insect repellents need to be 50 per cent DEET—the active ingredient which repels pests like midges and mosquitos. Other measures include staying in places with air conditioning or window screens with fine mesh to keep out midges and using insecticide-treated fine mesh bed nets. What is the cause and how is it treated? Oropouche virus is an RNA virus that belongs to the Simbu serogroup of the genus Orthobunyavirus in the family Peribunyaviridae, according to the US Centers for Disease Control and Prevention. Treatment is about managing symptoms: rest, drink plenty of fluids, and take paracetamol or other over-the-counter meds to ease fever and pain, the UKHSA says. If you develop severe symptoms, especially anything that might suggest brain involvement (like severe headache, confusion, or neck stiffness), the agency urges people to seek immediate medical help.
The Independent
30 minutes ago
- The Independent
You can now give yourself an at-home flu vaccine
For the first time, Americans can get their seasonal flu vaccine at home. Starting Friday, eligible adults in 34 states can order the FluMist Home - a nasal spray - online ahead of the upcoming flu season, European drugmaker AstraZeneca announced, calling it a 'transformational moment in the evolution of influenza protection.' FluMist was previously only available at pharmacies or doctors' offices. Now, interested people can go to to order the sprays, potentially saving time spent at a clinic or drug store. Once received, the vaccine should be stored in the refrigerator until it is used. Then, people between the ages of 18 and 49 years old can self-administer the vaccine. FluMist Home can be given to children and teens between the ages of two and 17 years old. A full dose is one spray in each nostril. FluMist may not prevent infection in everyone who takes it, but it works similarly to vaccines for measles and chickenpox. It contains weakened versions of viruses that trigger the immune system in the nose and throat, teaching it to build up immunity without causing infection. In rare cases, FluMist may cause serious side effects, including allergic reactions. But the most common side effects are a runny or stuffy nose, a sore throat and a fever of over 100 degrees. Some people should not take FluMist, including those with severe allergies to eggs, the vaccine's ingredients, or other flu vaccines, and kids who take aspirin or medicines containing aspirin. Children should also not take aspirin for four weeks after they get FluMist, unless told to do so by a healthcare provider. The spray, which was initially approved by the Food and Drug Administration in 2003 and was approved for at-home use without a healthcare professional last September, should be free for people with insurance, though there is an $8.99 shipping and processing fee. AstraZeneca said it hopes that all of the lower 48 states will have access to the spray in future flu seasons, although when that may be is unclear. The announcement comes on the heels of the worst flu season in 15 years, fueled by a cold winter, the spread of H5N1 bird flu, Covid, and other respiratory illnesses, and declining vaccine rates. Falling vaccination was 'a major cause of the surge,' Dr. Elizabeth Mack, the head of the pediatric critical care unit at the Medical University of South Carolina's Children's Health, told National Geographic. 'As influenza vaccination rates decline, especially among younger populations, this first-of-its-kind, at-home, needle-free option offers a critical opportunity to help make protection more accessible, convenient, and better aligned with the realities and current preferences of people's lives,' Dr. Ravi Jhaveri, the division head of infectious diseases at Northwestern University School of Medicine, said of FluMist Home, in a statement shared by AstraZeneca.
Reuters
31 minutes ago
- Reuters
Dow briefly hits record high on UnitedHealth boost; Trump-Putin meeting in focus
Aug 15 (Reuters) - The blue-chip Dow briefly hit a record high on Friday, as UnitedHealth's shares jumped after Berkshire Hathaway raised its stake in the health insurer, while investors assessed mixed data to determine the Federal Reserve's next monetary policy move. A meeting between U.S. President Donald Trump and Russian counterpart Vladimir Putin was also on the radar, with markets hoping it could pave the way for a resolution to the Ukraine conflict and determine the outlook for crude prices. The meeting is scheduled to take place at 1900 GMT. UnitedHealth Group (UNH.N), opens new tab gained almost 14% and was on track to log its biggest daily rise since 2008 after Warren Buffett's company (BRKa.N), opens new tab revealed a new investment in the health insurer, while Michael Burry's Scion Asset Management also turned more bullish on the company. Rising costs in the broader healthcare sector and about a 40% slump in UnitedHealth's shares this year have left the Dow (.DJI), opens new tab lagging its Wall Street peers on the road to record highs. The price-weighted index last scaled an all-time high on December 4. The healthcare sector (.SPXHC), opens new tab gained 1.8% on Friday and is on track for its best weekly performance since October 2022. At 2:04 p.m. the Dow Jones Industrial Average (.DJI), opens new tab rose 134.90 points, or 0.30%, to 45,046.70, the S&P 500 (.SPX), opens new tab lost 7.43 points, or 0.11%, to 6,461.11 and the Nasdaq Composite (.IXIC), opens new tab lost 57.72 points, or 0.27%, to 21,652.95. More broadly, Wall Street's main stock indexes are on track for their second week of gains, buoyed by expectations that the Fed could restart its monetary policy easing cycle with a 25-basis-point interest rate cut in September. The central bank last lowered borrowing costs in December and said U.S. tariffs could add to price pressures. However, recent labor market weakness and signs that tariff-induced inflation was yet to reflect in headline consumer prices have made investors confident of a potential dovish move next month. "The question is, has the tariff gotten into the price of goods yet? And it appears that there hasn't," said Joe Saluzzi, co-head of equity trading at Themis Trading. Saluzzi also said while markets have largely priced in a September rate cut, investors might be overlooking risks, with low volatility and rich valuations pointing to a sense of complacency. In a mixed day for economic data, a report showed retail sales in July rose as expected, but consumer confidence and factory production numbers indicated tariffs were taking a toll on other pockets of the economy. Chicago Fed President Austan Goolsbee was also cautionary in his remarks. Trump has said he will unveil tariffs on steel and semiconductors next week. Among other stocks that were on the move, Applied Materials (AMAT.O), opens new tab tumbled 14% after the chip equipment maker issued weak fourth-quarter forecasts. Shares of Bank of America (BAC.N), opens new tab dropped 1.4% after Berkshire Hathaway reduced its stake in the second-biggest U.S. lender by 4.2% to 605.3 million shares. It still owns about an 8% stake in BofA. Intel (INTC.O), opens new tab surged 5.7% after a report said the Trump administration was in talks for the U.S. government to potentially take a stake in the chipmaker. Declining issues outnumbered advancers by a 1.22-to-1 ratio on the NYSE. On the Nasdaq, declining issues outnumbered advancers by a 1.29-to-1 ratio. The S&P 500 posted 10 new 52-week highs and no new lows, while the Nasdaq Composite recorded 77 new highs and 72 new lows.
